• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

编码具有两个潜在跨膜结构域的酪氨酸激酶的原癌基因ret的克隆与表达。

Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains.

作者信息

Takahashi M, Buma Y, Iwamoto T, Inaguma Y, Ikeda H, Hiai H

机构信息

Laboratory of Experimental Pathology, Aichi Cancer Center Research Institute, Japan.

出版信息

Oncogene. 1988 Nov;3(5):571-8.

PMID:3078962
Abstract

The nucleotide sequence of the ret proto-oncogene has been determined from cDNA clones isolated from a cDNA library of a THP-1 human monocytic leukemia cell line. Analysis of this sequence indicates that it encodes a protein which is structurally related to transmembrane receptors with a cytoplasmic tyrosine kinase domain. Unlike most growth factor receptors, it contains two hydrophobic regions which are potential transmembrane domains. Comparison of the sequence of the ret proto-oncogene with that of the ret transforming gene revealed that, in addition to the amino-terminal truncation, the last 51 carboxy-terminal amino acids of the ret proto-oncogene were replaced with 9 unrelated amino acids of the ret transforming gene. The focus forming activity of the ret cDNA, containing both amino-terminal and caboxy-terminal truncations, was approximately 13-fold higher than that of cDNA containing only the amino-terminal truncation. This suggests a possible role for the carboxy-terminal sequence in activation of transforming potential of the ret proto-oncogene. When transcription of the ret proto-oncogene was examined in a variety of mouse tissues, we detected its transcription in normal mouse spinal cord and lymphadenopathy of C3H/HeJ-gld/gld and MRL/Mp-lpr/lpr mice.

摘要

已从人THP - 1单核细胞白血病细胞系的cDNA文库中分离出的cDNA克隆确定了原癌基因ret的核苷酸序列。对该序列的分析表明,它编码一种蛋白质,该蛋白质在结构上与具有细胞质酪氨酸激酶结构域的跨膜受体相关。与大多数生长因子受体不同,它包含两个疏水区域,这些区域是潜在的跨膜结构域。将原癌基因ret的序列与ret转化基因的序列进行比较发现,除了氨基末端截短外,原癌基因ret的最后51个羧基末端氨基酸被ret转化基因的9个不相关氨基酸所取代。包含氨基末端和羧基末端截短的ret cDNA的集落形成活性比仅包含氨基末端截短的cDNA高约13倍。这表明羧基末端序列在激活原癌基因ret的转化潜能中可能起作用。当在多种小鼠组织中检测原癌基因ret的转录时,我们在正常小鼠脊髓以及C3H/HeJ - gld/gld和MRL/Mp - lpr/lpr小鼠的淋巴结病中检测到了它的转录。

相似文献

1
Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains.编码具有两个潜在跨膜结构域的酪氨酸激酶的原癌基因ret的克隆与表达。
Oncogene. 1988 Nov;3(5):571-8.
2
cDNA cloning of mouse ret proto-oncogene and its sequence similarity to the cadherin superfamily.小鼠原癌基因ret的cDNA克隆及其与钙黏蛋白超家族的序列相似性。
Oncogene. 1993 Apr;8(4):1087-91.
3
Isolation of ret proto-oncogene cDNA with an amino-terminal signal sequence.分离具有氨基末端信号序列的ret原癌基因cDNA。
Oncogene. 1989 Jun;4(6):805-6.
4
Identification and analysis of the ret proto-oncogene promoter region in neuroblastoma cell lines and medullary thyroid carcinomas from MEN2A patients.在神经母细胞瘤细胞系及MEN2A患者的甲状腺髓样癌中对ret原癌基因启动子区域的鉴定与分析。
Oncogene. 1992 Jun;7(6):1201-6.
5
Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.RET/PTC3的分子特征;人类甲状腺乳头状癌中RET原癌基因的一种新的重排形式
Oncogene. 1994 Feb;9(2):509-16.
6
Characterization of ret proto-oncogene mRNAs encoding two isoforms of the protein product in a human neuroblastoma cell line.在人神经母细胞瘤细胞系中对编码两种蛋白产物异构体的原癌基因ret信使核糖核酸的特性分析。
Oncogene. 1990 Jan;5(1):97-102.
7
PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.PTC是原癌基因ret的一种新型重排形式,在人类甲状腺乳头状癌的体内经常被检测到。
Cell. 1990 Feb 23;60(4):557-63. doi: 10.1016/0092-8674(90)90659-3.
8
Cloning of an activated human ret gene with a novel 5' sequence fused by DNA rearrangement.通过DNA重排融合新的5'序列克隆活化的人类ret基因。
Gene. 1991 Nov 15;107(2):323-8. doi: 10.1016/0378-1119(91)90334-8.
9
Cloning and characterization of H4 (D10S170), a gene involved in RET rearrangements in vivo.H4(D10S170)基因的克隆与鉴定,该基因参与体内RET重排。
Oncogene. 1994 Sep;9(9):2531-5.
10
Activation of the ret-II oncogene without a sequence encoding a transmembrane domain and transforming activity of two ret-II oncogene products differing in carboxy-termini due to alternative splicing.ret-II癌基因的激活,该基因没有编码跨膜结构域的序列,以及由于可变剪接导致羧基末端不同的两种ret-II癌基因产物的转化活性。
Oncogene. 1989 Jun;4(6):789-94.

引用本文的文献

1
Explainable artificial intelligence of DNA methylation-based brain tumor diagnostics.基于DNA甲基化的脑肿瘤诊断的可解释人工智能
Nat Commun. 2025 Feb 20;16(1):1787. doi: 10.1038/s41467-025-57078-0.
2
Pathogenesis and Management Strategies in Radioiodine-Refractory Differentiated Thyroid Cancer: From Molecular Mechanisms Toward Therapeutic Approaches: A Comprehensive Review.放射性碘难治性分化型甲状腺癌的发病机制与治疗策略:从分子机制到治疗方法的全面综述
J Clin Med. 2024 Nov 26;13(23):7161. doi: 10.3390/jcm13237161.
3
Molecular genetics, therapeutics and RET inhibitor resistance for medullary thyroid carcinoma and future perspectives.
分子遗传学、治疗学和 RET 抑制剂耐药性在甲状腺髓样癌中的应用及未来展望。
Cell Commun Signal. 2024 Sep 28;22(1):460. doi: 10.1186/s12964-024-01837-x.
4
Non-Small-Cell Lung Cancers (NSCLCs) Harboring RET Gene Fusion, from Their Discovery to the Advent of New Selective Potent RET Inhibitors: "Shadows and Fogs".携带RET基因融合的非小细胞肺癌(NSCLCs):从发现到新型强效选择性RET抑制剂的出现——“阴影与迷雾”
Cancers (Basel). 2024 Aug 19;16(16):2877. doi: 10.3390/cancers16162877.
5
Discovery of 9H-pyrimido[4,5-b]indole derivatives as dual RET/TRKA inhibitors.发现 9H-嘧啶并[4,5-b]吲哚衍生物作为双重 RET/TRKA 抑制剂。
Bioorg Med Chem. 2024 May 15;106:117749. doi: 10.1016/j.bmc.2024.117749. Epub 2024 May 9.
6
Cryo-electron Microscopic Analysis of Single-Pass Transmembrane Receptors.冷冻电镜分析单次跨膜受体
Chem Rev. 2022 Sep 14;122(17):13952-13988. doi: 10.1021/acs.chemrev.1c01035. Epub 2022 Jun 17.
7
RET c.1901G>A and Novel SLC12A3 Mutations in Familial Pheochromocytomas.RET c.1901G>A 及家族性嗜铬细胞瘤中的新型 SLC12A3 突变。
Genes (Basel). 2022 May 12;13(5):864. doi: 10.3390/genes13050864.
8
The gene encodes RET protein, which triggers intracellular signaling pathways for enteric neurogenesis, and mutation results in Hirschsprung's disease.该基因编码RET蛋白,RET蛋白可触发肠道神经发生的细胞内信号通路,而该基因突变会导致先天性巨结肠症。
AIMS Neurosci. 2022 Mar 16;9(1):128-149. doi: 10.3934/Neuroscience.2022008. eCollection 2022.
9
RET receptor signaling: Function in development, metabolic disease, and cancer.RET 受体信号转导:在发育、代谢疾病和癌症中的功能。
Proc Jpn Acad Ser B Phys Biol Sci. 2022;98(3):112-125. doi: 10.2183/pjab.98.008.
10
Case report: identification of fusion in a patient with pancreatic ductal adenocarcinoma.病例报告:一名胰腺导管腺癌患者中融合基因的鉴定。
Gland Surg. 2021 Sep;10(9):2874-2879. doi: 10.21037/gs-21-469.